VKVyacheslav Andreevich Korepanov

Vyacheslav Andreevich Korepanov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Vyacheslav Andreevich Korepanov has a total of 92 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Beta-adrenergic receptors expression in cardiomyocytes with structural and functional myocardial changes in patients with chronic heart failure with preserved ejection fraction

    by E. F. Muslimova, V. A. Korepanov, T. Yu. Rebrova, D. V. Timofeev, B. N. Kozlov, S. A. Afanasiev, Э. Ф. Муслимова, В. А. Корепанов, Т. Ю. Реброва, Д. В. Тимофеев, et al.

    Introduction. Chronic hypersympathicotonia, excessive stimulation of beta-adrenergic receptors (beta-ARs) are key drivers of myocardial remodeling in chronic heart failure (CHF). Beta1-ARs desensitization is a compensatory mechanism limiting catecholamines damaging effects, but its progression exacerbates contractile dysfunction. Beta2-ARs exert predominantly protective effects, attenuating the cardiotoxicity of chronic catecholamine exposure. Of particular interest is the study of these processes in CHF with preserved ejection fraction (HFpEF) in the absence of myocardial infarction, rhythm disturbances, or valvular defects. Aim: To evaluate ADRB1 , ADRB2 genes expression levels and beta1-, beta2-adrenergic receptors myocardial content in HFpEF depending on the presence of structural, functional changes in the myocardium. Material and Methods. A total of 115 patients (65±6.9 years) with coronary artery disease, hypertension, HFpEF were included. ADRB1 , ADRB2 expression (digital droplet PCR), beta1-, beta2-AR levels (ELISA) were determined in right atrial appendage biopsies. Erythrocyte membranes beta-adrenergic reactivity (beta-ARM) was assessed in the blood. Results. Beta-ARM didn't differ between CHF functional classes, in patients with left ventricular (LV) hypertrophy, left atrial (LA) dilation, diastolic dysfunction and without them. With LA dilation, a significant decrease in beta1-AR levels was revealed (2.89 (1.91; 3.75) vs 3.54 (2.88; 4.82) ng/mg protein, p=0.014) with unchanged ADRB1 expression. A direct correlation was established between beta2-AR and end systolic (r=0.363, p=0.045), diastolic volumes (r=0.424, p=0.017), but ADRB2 , beta2-AR levels didn’t depend on the presence of LV hypertrophy or LA dilation. In obesity, beta1-AR higher level was recorded (3.82 (2.89; 4.54) vs 3.25 (2.27; 3.65), p=0.028), in diabetes mellitus 2, the ADRB2 expression was increased (0.017 (0.010; 0.036) vs 0.009 (0.006; 0.013), p=0.005). Conclusion. In patients with HFpEF without myocardial infarction, structural, functional myocardial changes weren’t accompanied by a significant increase in beta-ARM. Decreased beta1-AR level in cardiomyocytes are characteristic of LA dilation, but elevated beta2-AR correlated with increased LV volumes. Obesity was associated with higher beta1-AR level; diabetes mellitus was associated with increased ADRB2 gene expression. The CHF phenotype under study is characterized by a localized pattern of adrenergic dysregulation and divergent changes in the levels of beta-AR subtypes in cardiomyocytes, which are significantly influenced by metabolic disorders.

  • Open Access

    Oxidative stress severity and mitochondrial DNA polymorphisms in patients with heart failure at high risk of sudden cardiac death

    by T. Yu. Rebrova, V. A. Korepanov, M. V. Golubenko, E. F. Muslimova, T. A. Atabekov, S. V. Popov, S. S. Dorzhieva, A. A. Utusikova, S. A. Afanasyev, Т. Ю. Реброва, et al.

    Aim. To assess the severity of oxidative stress and the presence of polymorphic variants of mitochondrial deoxyribonucleic acid (mtDNA) in patients with heart failure (HF) and a high risk of sudden cardiac death (SCD). Material and methods . The study included 198 patients (78,79% men) diagnosed with HF and implantable cardioverter-defibrillators (ICDs) for the prevention of life-threatening ventricular tachycardia (VT) and SCD. The control group consisted of 28 healthy volunteers (men, 64,29%). Clinical and paraclinical parameters, plasma concentrations of thiobarbituric acid reactive lipid peroxidation substances (TBARS), superoxide dismutase (SOD) activity, and mtDNA polymorphisms A2706G/G3010A/G9055A were assessed. Results. Patients with HF and a high risk of SCD had significantly higher TBARS and SOD levels compared to the control group. In the healthy volunteer group, men had higher TBARS levels and reduced SOD activity compared to women. In HF, sex differences were negated. Registered VT did not affect TBARS levels or SOD activity. Type 2 diabetes, obesity, and dyslipidemia in patients with HF and a high risk of SCD was associated with a significant increase in TBARS. Carriers of the G9055A polymorphism showed significantly lower TBARS concentrations compared to carriers of the A2706G polymorphism. Conclusion. HF with a high risk of SCD is characterized by pronounced oxidative stress. Lipid peroxidation under normal conditions is significantly higher in men with reduced SOD activity. Impaired glucose and lipid metabolism in HF with a risk of SCD is accompanied by even more intense TBARS formation with unchanged SOD activity. Carriage of the G9055A mtDNA polymorphism is associated with low TBARS levels.

  • Assessment of the myocardial beta‑adrenergic activity in patients with chronic coronary artery disease with preserved and reduced left ventricular ejection fraction and the need for inotropic support after coronary artery bypass grafting

    by S. A. Afanasyev, D. S. Kondratieva, E. F. Muslimova, V. A. Korepanov, V. V. Zatolokin, S. L. Andreev

    Aim . To assess the myocardium inotropic reserve in patients with chronic coronary artery disease (CAD) with preserved and reduced left ventricular ejection fraction (LVEF) in β1- and β2-adrenoreceptor (AR) stimulation, and the need for inotropic support after surgical treatment of CAD. Material and methods . Inotropic responses of isolated myocardial trabeculae to β1- and β2-AR stimulation were studied in 16 patients with preserved LVEF and 17 patients with reduced LVEF. The inotropic response of trabeculae was assessed in isometric mode. Agonists were used to effect β1- and β2-AR against the background of preliminary α-AR block. All patients underwent coronary artery bypass grafting. Vasoactive inotropic score (VIS) in the postoperative period was calculated. Results . Adrenergic activity of trabeculae in patients with preserved LVEF is provided by β1-AR, and in patients with reduced LVEF — by β2-AR, which is 150 (138; 163)% and 139 (120; 193)%, respectively. In this case, the total β-adrenergic reactivity of the trabeculae with reduced LVEF is lower than with preserved LVEF (p=0,034). VIS in reduced LVEF exceeded the threshold values and was three times higher than with preserved LVEF (p=0,007). Conclusion . In chronic CAD, the myocardium retains pronounced β-adrenergic reactivity. With preserved LVEF, the main contribution to myocardial β-adrenergic reactivity is made by β1-AR. With reduced LVEF, β-adrenergic reactivity is determined by β2-AR, but this does not completely compensate inotropic effects. This fact may probably be one of the reasons for greater need for postoperative inotropic support in patients with reduced LVEF.

  • Open Access

    Genetic and functional features of peripheral blood leukocyte mitochondria in patients with coronary heart disease and high risk of sudden cardiac death

    by V. A. Korepanov, T. A. Atabekov, M. V. Golubenko, N. R. Valiakhmetov, N. P. Babushkina, R. E. Batalov, S. A. Afanasiev, A. A. Garganeeva

    Aim. To assess the relationship between the respiration of mitochondria of peripheral blood leukocytes and mitochondrial DNA (mtDNA) polymorphism in patients with coronary heart disease (CHD) depending on the risk of developing sudden cardiac death (SCD). Materials and methods. We formed two groups of patients: the main group – patients with CHD and the high risk of SCD ( n = 107); the comparison group – patients with stable course of CHD without the risk of SCD ( n = 50). Using methods of high-throughput sequencing, we determined patients’ haplogroup and carriage of mtDNA polymorphisms A2706G, G3010A and G9055A. The respiratory activity of isolated mitochondria from peripheral blood leukocytes was assessed by amperometric method using NADand FAD-dependent oxidation substrates. Results. In both studied groups, H, U, and J haplogroups were predominant (74.5% and 92.5%, respectively, for the main group and the comparison group). There were more minor haplogroups in the main group than in the comparison group. The frequencies of occurrence of polymorphisms A2706G, G3010A, and G9055A did not significantly differ between the groups. In the main group, carriage of the A2706G polymorphism was associated with a decrease in the respiratory control ratio (RC) in FAD-dependent respiration ( p = 0.05), and in the comparison group it was associated with a decrease in oxygen consumption rate (OCR) in the V4 metabolic state in both NADand FAD-dependent respiration ( p = 0.002 and p = 0.008, respectively) without changing in RC. In the main group, carriage of the G9055A polymorphism was associated with a decrease in OCR in the V3 metabolic state ( p = 0.037) in FAD-dependent respiration. For the G3010A polymorphism, no association with mitochondrial respiration was found in the studied groups. Conclusion. In patients with CHD, regardless of the risk of SCD, the frequencies of haplogroups H, U, and J and mtDNA polymorphisms A2706G, G3010A, and G9055A do not differ significantly. In patients with high risk of SCD, carriage of the A2706G polymorphism is associated with a decrease in RC in FAD-dependent respiration, and the G9055A polymorphism is associated with a decrease in OCR in V3 during FAD-dependent respiration.


  • Open Access

    Effects of nitric oxide on sympathoadrenal system activity in patients with ischemic heart disease in coronary artery bypass grafting

    by T. Yu. Rebrova, Yu. K. Podoksenov, V. A. Korepanov, E. A. Churilina, N. O. Kamenshchikov, E. F. Muslimova, I. N. Vorozhtsova, S. A. Afanasiev

    Aim. To investigate changes in laboratory parameters of sympathoadrenal system activity and β-adrenergic receptor reactivity of erythrocyte membranes (β-ARMe) in ischemic heart disease (IHD) patients with clinical forms of arterial hypertension of high cardiovascular risk during coronary artery bypass grafting with anesthetic management including nitric oxide.Materials and мethods. In this randomized study with parallel distribution, 36 patients (male – 66.7%; average age – 68 [63; 70] years) with IHD and clinical forms of arterial hypertension of high cardiovascular risk were enrolled. According to the indications, all patients underwent elective coronary artery bypass grafting (CABG) using extracorporeal circulation (ECC). Patients were randomly divided into the main and control groups. Patients of the main group intraoperatively received NO at the concentration of 80 ppm first in the breathing circuit and then in the ECC circuit. Patients of the control group underwent CABG with standard mechanical lung ventilation and ECC. Before connecting to the ECC, at the end of ECC, and 1 day after CABG, all patients underwent clinical, laboratory, and instrumental tests in accordance with the clinical standards, β-ARMe was assessed, and the concentration of norepinephrine and epinephrine in the blood plasma was determined by ELISA.Results. At the presurgical stage and 1 day after CABG, the groups did not differ in clinical and biochemical parameters. At the presurgical stage, the median values of β-ARMe in the main and control groups slightly exceeded the upper limits of normal and did not differ significantly. CABG was not accompanied by changes in β-ARMe in the control group. Intrasurgical NO donation also did not affect the level of β-ARMe. One day after CABG, neither intergroup differences in β-ARMe nor significant changes in the parameter during follow-up in each group were noted. In both control and main groups, a significant increase in the levels of epinephrine and norepinephrine was detected 1 day after CABG compared to the baseline level. At the same time, there were no intergroup differences in the level of catecholamines either before ECC or 1 day after CABG.Conclusion. In cardiac surgery with extracorporeal circulation, the use of NO for the purpose of organ protection does not affect the level of β-ARMe and changes in the mediator response of the sympathetic system to stress in patients with IHD and clinical forms of hypertension of high cardiovascular risk.

  • Open Access

    Rare missense substitutions in the mitochondrial DNA genes in patients with ventricular tachycardia

    by M. V. Golubenko, N. P. Babushkina, V. A. Korepanov, N. R. Valiakhmetov, T. A. Atabekov, K. N. Vitt, A. A. Zarubin, O. A. Makeeva, S. A. Afanasiev, R. E. Batalov, et al.

    Human mitochondrial DNA (mtDNA) exhibits high population-level polymorphism. While certain pathogenic mtDNA variants are known to cause hereditary mitochondrial syndromes, often presenting with cardiac arrhythmias, life-threatening ventricular tachycardia (VT) itself is a major risk factor for sudden death in cardiovascular diseases.   The aim of the work was to study rare (“private”) missense substitutions in the mtDNA of patients with documented episodes of ventricular tachycardia in comparison with patients with ischemic heart disease without life-threatening heart arrhythmias and individuals without clinical manifestations of cardiovascular diseases. The sequencing of mtDNA was performed using high-throughput sequencing methods. Specialized algorithms predicting the effect of gene variants were used to assess the effect of missense substitutions. Comparative analysis of the spectrum of the identified amino acid substitutions in the studied groups showed that about 40 % of the individuals in all three groups were carriers of “private” missense variants in mtDNA. However, among such substitutions, the variants classified by the APOGEE2 predictor as “variants of uncertain significance” (VUS) were more common in the group of patients with heart arrhythmias than in the control group, where “private” missense substitutions of the VUS category were not detected (p = 0.0063 for Fisher’s exact test). In addition, the groups differed in their phred-ranked Combined Annotation Dependent Depletion (CADD) scores, which were lower for individuals in the control group. The results indicate that rare mtDNA variants may contribute to predisposition to cardiovascular disease – in particular, to the risk of developing ventricular tachycardia by some patients.


  • Open Access

    Chronic heart failure with reduced and mildly reduced left ventricle ejection fraction: relationship between mitochondrial respiratory dysfunction of peripheral blood mononuclear cells and iron deficiency

    by Alla A Garganeeva, Viacheslav A. Korepanov, Elena A Kuzheleva, Olga V Tukish, Karina N Vitt, Elvira F Muslimova, Sergey A Afanasiev

    Objectives To compare respiratory parameters of peripheral blood mononuclear cell mitochondria and iron metabolism indicators in patients with different NYHA functional classes of ischemic heart failure (HF). Methods This single center, prospective, non-blinded study enrolled 20 patients with diagnosed chronic HF of ischemic genesis with reduced and mildly reduced left ventricle ejection fraction. The maximum oxygen consumption at the peak of the exercise test (VO2 peak), iron metabolism parameters and respiratory activity of peripheral blood mononuclear cell mitochondria were assessed. Results Among the patients, a half of individuals were diagnosed with iron deficiency. Subgroups of patients with different HF severity did not significant differ in VO2 peak (P = 0.209), serum iron (P = 0.468) and ferritin (P = 0.235) levels. But there was a trend in increasing in these parameters with increasing NYHA HF functional class. Respiratory control coefficient (RC) in NAD-dependent and FAD-dependent mitochondrial oxidation were lower in patients with NYHA HF III functional class compared to individuals with NYHA HF I functional class (P = 0.028 and P = 0.040, respectively). Serum iron (P = 0.026), ferritin (P = 0.045) levels, transferrin saturation (P = 0.006) were negatively correlated with RC in NAD-dependent mitochondrial oxidation. Conclusions In aggravation of ischemic HF NYHA FC, there is a decrease in RC of PBMC mitochondria during the oxidation of NAD-dependent and FAD-dependent substrates. In the whole sample, patients with laboratory-confirmed iron deficiency accounted a half of the total number. Iron metabolism parameters had a paradoxical inverse relationship with the level of RC in PBMC mitochondria of patients with HF.


  • Open Access

    Mitochondrial DNA Polymorphisms of Peripheral Blood Mononuclear Cells Associated with Sustained Ventricular Tachycardia in Patients with Cardioverter-Defibrillator Implantation Indications

    by Tariel Atabekov, Viacheslav Korepanov, Sergey Krivolapov, Mikhail Khlynin, Sergey Afanasiev, Maria Golubenko, Roman Batalov, Sergey Popov

    Background: Mitochondrial dysfunction in myocardium cells has been implicated in arrhythmogenesis, including ventricular tachycardia (VT). A carriage of point mitochondrial DNA (mtDNA) polymorphisms may contribute to the risk of certain arrhythmias. Therefore, it is hypothesized that mtDNA genotype could predict the risk of sustained VT (SVT). We aimed to explore whether specific mtDNA polymorphisms of peripheral blood mononuclear cells (PBMC) can serve as biomarkers for predicting the risk of SVT in patients with indications for an implantable cardioverter-defibrillator (ICD). Methods: A total of 122 patients with ICD implantation indications who underwent transthoracic echocardiography (TTE) were enrolled in the study. Total DNA from PBMC was isolated using the phenol-chloroform extraction method. Genotyping of mtDNA polymorphisms A2706G, G3010A and G9055A was performed using restriction fragment length polymorphism analysis. Correlations between clinical parameters and mtDNA polymorphisms with SVT registered prior to ICD implantation were evaluated. Based on our data, we developed a risk model for SVT. Results: Prior to ICD implantation, 70 (56.6%) patients had SVT (1st group) and 52 (43.4%) patients did not have SVT (2nd group). Patients with SVT were significantly older than patients without SVT (66.9 ± 9.9 year vs. 59.5 ± 10.6 year, p < 0.001), had a lower value estimated glomerular filtration rate (eGFR) (65.7 ± 19.7 mL/min/1.73 m2 vs. 77.9 ± 16.1 mL/min/1.73 m2, p < 0.001) and less frequently had A2706G mtDNA polymorphism (55.7% vs. 76.9%, p = 0.015). According to the multivariable logistic regression, age (odds ratio (OR) = 1.055, 95% confidence interval (CI) 1.009–1.103, p = 0.017), eGFR (OR = 0.974, 95% CI 0.949–0.999, p = 0.041) and absence of A2706G mtDNA polymorphism (OR = 0.335, 95% CI 0.141–0.797, p = 0.013) were independently associated with the SVT. We constructed a logistic equation with calculation of the cut-off value. The discriminative ability of the receiver operating characteristic curve (area under the curve) was 0.761 (95% confidence interval 0.675–0.833; sensitivity 65.71%; specificity 76.92%). Conclusions: In patients with ICD implantation indications, a carriage of mtDNA polymorphism A2706G is associated with SVT. Our risk model including age, eGFR and absence of A2706G mtDNA substitution was able to distinguish patients with SVT. Further investigations of their predictive significance are warranted. Clinical Trial Registration: NCT03667989 (https://clinicaltrials.gov/study/NCT03667989).


  • Open Access

    Acute Decompensated Heart Failure: Structural and Functional Changes in Mitochondria

    by A. A. Garganeeva, E. A. Kuzheleva, O. V. Tukish, K. N. Vitt, M. Yu. Kondratiev, E. E. Syromyatnikova, S. L. Andreev, Yu. A. Arsenieva, V. A. Korepanov, S. A. Afanasiev

    Aim . Comparative assessment of structural changes in cardiomyocyte mitochondria of the right atrial appendage and the mitochondrial respiratory function in peripheral blood leukocytes in a cohort of patients after acute decompensated heart failure (ADHF) and with stable chronic heart failure of ischemic etiology with reduced ejection fraction (CHFrEF) or moderately reduced ejection fraction (CHFmrEF) of the left ventricle. Material and methods . The study analyzed 40 micrographs of right atrial appendage cardiomyocytes obtained from 12 patients with CHFrEF and CHFmrEF. The study protocol was registered on ClinicalTrials.gov: NCT05770349. Electron microscopy was performed with a JEM-1400 transmission electron microscope (Subdiffraction Microscopy Collective Use Center at the Electron Microscopy Department of the Belozersky Research Institute of Physico-Chemical Biology, Lomonosov Moscow State University). The total area of interfibrillar mitochondria was calculated as a ratio of the total surface area of mitochondria located between the cardiomyocyte contractile fibers to the total area of the interfibrillar space. The respiratory activity of isolated mitochondria was assessed in oxygenated standard incubation media. Patients were divided into two groups based on the occurrence of an ADHF episode within 12 months before inclusion in the study: Group 1 (n=19), patients without ADHF and Group 2 (n=21), patients with an episode of ADHF. Results . Most of the clinical and anamnestic parameters were comparable between the study groups. Analysis of the mitochondrial respiratory function in peripheral blood leukocytes showed reduced values of the respiratory control level (RCL) in both study groups, 2.14 [2; 2.32] and 2.55 [1.36; 2.84] conv. units. The total area of interfibrillar mitochondria was 41.7 [32; 58]% in the group without ADHF and 33 [21; 46]% in patients with ADHF (p=0.048); significant correlations were found between this parameter and the distance walked in the 6-min walk test (r=0.482; p=0.002) and the peak oxygen consumption during exercise (r=0.395; p=0.012). A ROC analysis was used to determine a threshold value of the total area of interfibrillar mitochondria in patients with ADHF: the cutoff point was 32%. Conclusion . A decrease in the total area of interfibrillar mitochondria of the right atrial appendage cardiomyocytes of less than 32% as measured by electron microscopy is characteristic of patients with a previous episode of ADHF with reduced and moderately reduced left ventricular ejection fraction. The study results confirm the development and persistence of ultrastructural changes in cardiomyocytes after ADHF.

  • Open Access

    Possibilities of mitochondrial dysfunction diagnosis in chronic heart failure

    by A. A. Garganeeva, E. A. Kuzheleva, O. V. Tukish, K. N. Vitt, S. L. Andreev, E. F. Muslimova, V. A. Korepanov, S. A. Afanasiev, M. O. Gulya, E. E. Syromyatnikova, et al.

    The article presents preliminary study results of association of direct ultrastructural characteristics of mitochondria (MTC) in cardiomyocytes and indirect signs of mitochondrial dysfunction with clinical course and outcomes of chronic heart failure (CHF). According to electron microscopy of the myocardium a violation of the ultrastructure of MTC of cardiomyocytes is accompanied by a decrease in the rate of oxygen absorption by mitochondria of leukocytes of peripheral blood, separation of oxidation and phosphorylation processes, an increased rate of radiopharmaceuticals leaching from myocardium, indicating mitochondrial membrane damage, low tolerance to physical load and reduced oxygen consumption at peak of load test, which confirms the feasibility of studying associations of indirect signs of mitochondrial dysfunction with ultrastructural changes in the mitochondrial cardiomyocytes and clinical manifestations of heart failure.